

Behind Every Therapy: Exploring the Role of Analytics and Biosafety in Bringing Medicines to Market
This event is part of BioBuzz’s Insights to Impact Series, a curated program designed exclusively for life sciences industry leaders and ecosystem builders. Our guest list is intentionally built to foster a high-quality, peer-driven experience.
Overview
In today’s life sciences landscape, analytical science is no longer a back-end function — it is a strategic driver of success across development, regulatory approval, and commercialization. From biologics to gene therapies, the ability to generate accurate, reproducible, and regulatory-ready analytical data determines speed to market, patient safety, and long-term product viability.
Join BioBuzz and Minaris Advanced Testing for a high-impact, two-part executive panel event exploring the evolving role of analytical sciences in biotech and advanced therapeutics.
Agenda
4:30 PM Check-In + Networking
5:00 PM Welcome + Opening Remarks
5:05 PM Why Analytical Science Is Central to Life Sciences Success [Panel 1]
A high-level discussion exploring how analytical science and biosafety testing enable innovation, manage risk, and accelerate commercialization. Geared toward a mix audience of both biotech companies and ecosystem partners.
Speakers:
Jennifer Hayne, VP & Head of Biologics Analytical Services, Catalent
Therese Choquette, CTO, Tigen Pharma
Catherine Willis, Director of Quality Control, St. Jude
Joe Payne, Consultant, JEP Consultant Services (Moderator)
5:40 PM Modernizing Analytics in a Rapidly Evolving Landscape [Panel 2]
A deeper technical conversation for scientists, technical leaders, and innovation-focused stakeholders on how regulatory evolution and emerging technologies are reshaping analytical science.
Speakers:
Christopher Larson, Vice President, Quality Control, Castle Creek Biosciences
Joe Newcome, Senior Director, Analytical Sciences, Minaris Advanced Testing
Andrea Moore, VP, Analytical Development and Quality Control, AskBio
Audrey Chang, CMC Scientific Advisor, Minaris Advanced Testing (Moderator)
6:20pm Networking + Tours of Minaris Testing Labs
Venue
Join us at the headquarters of Minaris and home of Minaris Advanced Testing.
This purpose-built testing 140,000 square foot facility integrates molecular biology, virology, microbiology and quality control laboratories under one roof, enabling seamless coordination across testing disciplines. The facility is designed to meet the highest regulatory standards and provide world-class GMP-compliant biosafety and analytical testing services for mAbs, viral vaccines, and cell and gene therapies.
Learn more at minaris.com
Lead Sponsor & Host
Minaris (minaris.com)
Partners
This event is made possible by the support of our sponsors:
Conner Strong & Buckelew (connerstrong.com)
CRB (www.crbgroup.com)
Heffron (heffroncompany.com)
Kymanox (kymanox.com)
TEDCO (tedcomd.com)
Workforce Genetics (workforcegenetics.com)
Important Information
We encourage you to share this with those in your network who are passionate about strengthening Philadelphia's biotech ecosystem and would benefit from attending.
NOTE TO VENDORS + SERVICE PROVIDERS
Vendor and Service Provider attendance is limited to ensure a high-quality, peer-driven industry experience. A select number of Vendor / Service Provider tickets ($75) are available using access code VENDOR.
Vendors and Service Providers operating in the same category as any of our sponsors will require pre-authorization from the associated sponsor. BioBuzz reserves the right to restrict registration and entry as necessary. Refunds will be provided when tickets cannot be honored.